Pathomorphology of pretumor condition and lung cancer in persons engaged in radionuclide industry

A. E. Ali-Risa, T. G. Barkhina, M. V. Samsonova, A. L. Cherniaev (Moscow, Russia)

Source: Annual Congress 2004 - Mesothelioma and malignant pleural effusions - pollution and cancer
Session: Mesothelioma and malignant pleural effusions - pollution and cancer
Session type: Thematic Poster Session
Number: 3289
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. E. Ali-Risa, T. G. Barkhina, M. V. Samsonova, A. L. Cherniaev (Moscow, Russia). Pathomorphology of pretumor condition and lung cancer in persons engaged in radionuclide industry. Eur Respir J 2004; 24: Suppl. 48, 3289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How should PET influence the management of lung cancer?
Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?
Year: 2013


Does surgical lung biopsy help patients with interstitial lung disease? Views of pulmonologists in China
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Management of lung cancer in the elderly
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Bronchial epithelium changes in patients engaged in radionuclide industry
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Interstitial lung diseases in a lung cancer screening trial
Source: Eur Respir J 2011; 38: 392-400
Year: 2011



Epidemilogy of selected occupational lung diseases in Slovakia
Source: Eur Respir J 2006; 28: Suppl. 50, 464s
Year: 2006

Accompanying diseases in lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006

The Asian experience in co-existing lung cancer and interstitial lung disease
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Clinical feature of elderly patients with lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Prevalence of bronchiectasis in a lung cancer screnning program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


Asymptomatic brain metastases in lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Air travel in patients with advanced lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 326s
Year: 2003

Lung asbestos content in patients with lung cancer in different Spanish regions. The AMCANES study
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016